Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015)

Rocket Pharmaceuticals (RCKT) posted Other Non Operating Income of $38.4 million for Q4 2015, up 182.3% sequentially from -$46.6 million in Q3 2015.

Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015) Analysis & Trends

Rocket Pharmaceuticals has reported Other Non Operating Income for 1 years, with the latest figure at $38.4 million in Q4 2015.

Quarterly Other Non Operating Income changed N/A year-over-year to $38.4 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was -$7.1 million (changed N/A YoY) and the FY2015 annual result came in at -$4.4 million, changed N/A from the prior year.
Other Non Operating Income grew to $38.4 million in Q4 2015 per RCKT's latest filing, from -$46.6 million in the prior quarter.
Over five years, Other Non Operating Income peaked at $38.4 million in Q4 2015 and troughed at -$46.6 million in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Rocket Pharmaceuticals	380.92 Mn	380.92 Mn	-

Download Data